| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/31/2001 | WO2001037868A1 Assays and therapies for latent viral infection |
| 05/31/2001 | WO2001037864A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | WO2001037860A1 Method of inducing immune tolerance |
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037779A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 05/31/2001 | WO2001009186A3 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
| 05/31/2001 | WO2000072880A3 Prevention and treatment of amyloidogenic disease |
| 05/31/2001 | WO2000071748A3 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants |
| 05/31/2001 | WO2000066708A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/31/2001 | WO2000061754A3 Human proteins and polynucleotides encoding them |
| 05/31/2001 | WO2000042165A3 Bone marrow-specific protein |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/31/2001 | WO1999028462A9 Polypeptides and nucleic acids encoding the same |
| 05/31/2001 | WO1999024553A9 X-ray crystal comprising hiv-1 gp120 |
| 05/31/2001 | US20010002393 Administering to a patient suffering from leiomyoma (fibroid)of uterus an effective dose of an agent which specifically inhibit metalloproteinase selected from stromelysin-2, stromelysin-3 and matrilysin |
| 05/31/2001 | DE19952509A1 Polyclonal antiserum against human leucocyte antigen-G, useful for predicting success of in vitro fertilization and for prognosis of melanoma |
| 05/31/2001 | CA2429394A1 Method of inducing immune tolerance |
| 05/31/2001 | CA2394914A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | CA2394803A1 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | CA2393126A1 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/31/2001 | CA2392649A1 Assay of isomerised and/or optically inverted proteins |
| 05/31/2001 | CA2392639A1 G-protein coupled receptor htogh35 |
| 05/31/2001 | CA2392475A1 Moss genes from physcomitrella patens coding proteins involved in the synthesis of polyunsaturated fatty acids and lipids |
| 05/31/2001 | CA2392456A1 Assays and therapies for latent viral infection |
| 05/31/2001 | CA2392400A1 A human normal counterpart of cd4+ cd56+ cutaneous neoplasm |
| 05/31/2001 | CA2392375A1 Synthetic oligomannosides, preparation and uses thereof |
| 05/31/2001 | CA2392366A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2392351A1 Novel transcription factor and dna thereof |
| 05/31/2001 | CA2390802A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 05/31/2001 | CA2390465A1 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2390344A1 85kda neisserial antigen |
| 05/31/2001 | CA2390095A1 Method and system to remove cytokine inhibitor in patients |
| 05/30/2001 | EP1103623A1 Human mucin core protein: nucleic acid probes, peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
| 05/30/2001 | EP1103606A2 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 05/30/2001 | EP1103562A1 Novel g-protein coupled receptor protein and dna thereof |
| 05/30/2001 | EP1102863A1 Mutations in and genomic structure of herg - a long qt syndrome gene |
| 05/30/2001 | EP1102853A1 N-acetylglycosaminyltransferase genes |
| 05/30/2001 | EP1102849A2 A plant disease resistance signalling gene: materials and methods relating thereto |
| 05/30/2001 | EP1102847A2 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents |
| 05/30/2001 | EP1102846A1 Pancreatic and ovarian polypeptide, zsig58 |
| 05/30/2001 | EP1102838A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 05/30/2001 | EP1102788A2 Prevention and treatment of viral disease |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/30/2001 | EP0662093B1 Hiv immunotherapeutics |
| 05/30/2001 | CN1297532A Identification of chemical active agents for inhibiting 1-desoxy-D-xylulose-5-phosphate biosynthetic pathway in parasites, and said active agents |
| 05/30/2001 | CN1297531A Isolated nucleic acid molecule encoding cancer associated antigens, antigens per se, and uses thereof |
| 05/30/2001 | CN1297482A Group B streptococcus antigens |
| 05/30/2001 | CN1297480A Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies |
| 05/30/2001 | CN1297454A Novel omega-conotoxin peptides |
| 05/30/2001 | CN1297357A Preventives or remedies for inflammatory intestinal diseases contg. as active ingredient IL-6 antagonists |
| 05/30/2001 | CN1297050A Polypeptide-human phosphatidic acid phosphatase 2-35 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1297045A Polypeptide-human UCT-isoenzyme 28 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296976A Polypeptide-human epidermal growth factor receptor protein 25 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296972A Polypeptide-human myosin heavy chain 74 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296971A Polypeptide-huntingtin protein interactive protein 65 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296969A Polypeptide-human X chromosome linked gene expression protein 14 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296965A Polypeptide-human fibrous growth factor receptor 46 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296963A Polypeptide-human vascular epithelium cadherin 54 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296961A Polypeptide-human CDC4 analogous protein 13 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296960A Polypeptide-human CCR4 related protein 31 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296958A Polypeptide-human G protein 44 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296955A Human susceptible protein and its coding sequence |
| 05/30/2001 | CN1296954A Human membrane protein containing C2 structural domain and its coding sequence |
| 05/30/2001 | CN1296953A Mycoplasma hyopnaumoniae (mhp) 3 gene nuclein and protein, and use thereof |
| 05/30/2001 | CN1296952A Polypeptide-complement receptor 222 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296951A Affinity preparing process of albumin and antibody |
| 05/30/2001 | CN1296851A Antivirus immune globulin for dog, fox and marten and its preparing process |
| 05/29/2001 | US6240336 Control unit for an irrigation system |
| 05/29/2001 | US6239269 Ryegrass pollen allergen |
| 05/29/2001 | US6239267 Nucleotide sequence of ion channel protein associated with capsaicin; diagnosis and treatment of nervous system disorders, incontinence, stroke; antiischemic agents; antiarthritic/antiinflammatory agents; analgesics |
| 05/29/2001 | US6239261 Pasteurized, purified von Willebrand factor concentrate and a process for the preparation thereof |
| 05/29/2001 | US6239259 Multivalent and multispecific antigen-binding protein |
| 05/29/2001 | US6239256 Isolated muteins of proteins SCP-1, and compositions containing the mutein |
| 05/29/2001 | US6239110 Synthetic analogs of thrombospondin and therapeutic use thereof |
| 05/29/2001 | US6239106 Family of protease inhibitors, and other biologic active substances |
| 05/29/2001 | US6238915 Protein for the treament of preferential genetic disorders |
| 05/29/2001 | US6238905 Nucleotide sequence coding enzymatic protein; for use as tool in genetic engineering; for use in detection of amplification proteins |
| 05/29/2001 | US6238900 Nucleotide sequence coding enzymatic polypeptide; for the prevention of bacterial infections; bactericides |
| 05/29/2001 | US6238894 Culture product of helicobacter; catalyst |
| 05/29/2001 | US6238892 Preferential immunoglobulin for the diagnosis and treatment of alzheimer's disease and nervous system disorders |
| 05/29/2001 | US6238890 Single chain forms of the glycoprotein hormone quartet |
| 05/29/2001 | US6238889 Amino acid sequence of interleukin-3; recombinant culture production |
| 05/29/2001 | US6238883 Neurotransmitter transporter SC6 |
| 05/29/2001 | US6238882 Nucleotide sequence from streptococcus; diagnosis; drug screening for new bactericides; primers; probes; antibodies; vaccines |
| 05/29/2001 | US6238881 Nucleotide sequence which codes for p115 rho-guanine exchange factor involved in cell signalling; therapeutics; diagnostics; recombinant culture production; antibodies; probes |
| 05/29/2001 | US6238875 Immunoassay diagnosis of chronic lymphocytic leukemia in humans by detecting and quantitating gene expression of effector cell protease receptors on cd5 positive sample cells |
| 05/29/2001 | US6238872 Inhibiting restenosis by inserting stent that has antigen attached, then administering antibody labeled with radioactive source; immunotherapy |
| 05/29/2001 | US6238861 Neurofibromatosis gene |
| 05/29/2001 | US6238860 Amino acid sequence of polypeptide which binds b19-polypeptide; detection in sample; removal from solution; testing transfusion blood supplies |
| 05/29/2001 | US6238676 Vaccine |
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
| 05/29/2001 | US6238667 Binding using an azidotrytophan compound |
| 05/29/2001 | US6238666 Polypeptide |
| 05/29/2001 | US6238664 Process for stabilizing proteins |
| 05/29/2001 | CA2171638C The semaphorin gene family |
| 05/29/2001 | CA2065292C Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
| 05/29/2001 | CA2064915C Tumour necrosis factor binding ligands |
| 05/25/2001 | WO2001036977A2 Identification of disease markers involving mass-based-separation |
| 05/25/2001 | WO2001036688A1 Method for detecting replication competent viruses in the sera of subjects receiving gene therapy |